Viewing Study NCT01352793


Ignite Creation Date: 2025-12-25 @ 1:08 AM
Ignite Modification Date: 2026-05-17 @ 1:55 PM
Study NCT ID: NCT01352793
Status: COMPLETED
Last Update Posted: 2015-03-11
First Post: 2011-05-11
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years
Sponsor:
Organization: